Amedeo Smart

Free Medical Literature Service

 

Amedeo

Neoplasms of the CNS
  Free Subscription

Articles published in
J Nucl Med
    February 2024
  1. EIGLER C, McDougall L, Bauman A, Bernhardt P, et al
    Radiolabeled Somatostatin Receptor Antagonist Versus Agonist for Peptide Receptor Radionuclide Therapy in Patients with Therapy-Resistant Meningioma: PROMENADE Phase 0 Study.
    J Nucl Med. 2024 Feb 29:jnumed.123.266817. doi: 10.2967/jnumed.123.266817.
    >> Share

  2. LOHMANN P, Gutsche R, Werner JM, Shah NJ, et al
    Example of Artificial Intelligence-Based Decision Support for Amino Acid PET: Early Prediction of Suspected Brain Tumor Foci for Patient Management.
    J Nucl Med. 2024 Feb 15:jnumed.123.267112. doi: 10.2967/jnumed.123.267112.
    >> Share

  3. TOLBOOM N, Verger A, Albert NL, Fraioli F, et al
    Theranostics in Neurooncology: Heading Toward New Horizons.
    J Nucl Med. 2024;65:167-173.
    >> Share

    October 2023
  4. MAULER J, Lohmann P, Maudsley AA, Sheriff S, et al
    Diagnostic Accuracy of MR Spectroscopic Imaging and (18)F-FET PET for Identifying Glioma: A Biopsy-Controlled Hybrid PET/MRI Study.
    J Nucl Med. 2023 Oct 26:jnumed.123.265868. doi: 10.2967/jnumed.123.265868.
    >> Share

    September 2023
  5. HABERBOSCH L, Gillett D, MacFarlane J, Koulouri O, et al
    Dual Role for l-[Methyl-(11)C]-Methionine PET in Acromegaly: Confirming Remission and Detecting Recurrence.
    J Nucl Med. 2023 Sep 28:jnumed.123.266446. doi: 10.2967/jnumed.123.266446.
    >> Share

    August 2023
  6. LOHMEIER J, Radbruch H, Brenner W, Hamm B, et al
    Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using (18)F-FET PET.
    J Nucl Med. 2023 Aug 31:jnumed.123.265642. doi: 10.2967/jnumed.123.265642.
    >> Share

  7. VAN LITH SAM, Pruis IJ, Tolboom N, Snijders TJ, et al
    PET Imaging and Protein Expression of Prostate-Specific Membrane Antigen in Glioblastoma: A Multicenter Inventory Study.
    J Nucl Med. 2023 Aug 31:jnumed.123.265738. doi: 10.2967/jnumed.123.265738.
    >> Share

  8. GUTSCHE R, Lowis C, Ziemons K, Kocher M, et al
    Automated Brain Tumor Detection and Segmentation for Treatment Response Assessment Using Amino Acid PET.
    J Nucl Med. 2023 Aug 10:jnumed.123.265725. doi: 10.2967/jnumed.123.265725.
    >> Share

  9. ALBERT NL, Nelwan DV, Fleischmann DF, Quach S, et al
    Prognostic Value of TSPO PET Before Radiotherapy in Newly Diagnosed IDH-Wild-Type Glioblastoma.
    J Nucl Med. 2023 Aug 3:jnumed.122.265247. doi: 10.2967/jnumed.122.265247.
    >> Share

    June 2023
  10. MILOSEVIC A, Styczen H, Grueneisen J, Li Y, et al
    Evaluation of [(68)Ga]-DOTATOC PET/MRI in Patients with Meningioma of the Subcranial and Intraorbital Space.
    J Nucl Med. 2023 Jun 29:jnumed.123.265424. doi: 10.2967/jnumed.123.265424.
    >> Share

    May 2023
  11. GALLDIKS N, Langen KJ
    Hybrid (18)F-FET PET and Perfusion MRI to Differentiate Disease Progression from Treatment-Related Changes in Malignant Brain Tumors.
    J Nucl Med. 2023 May 18:265647. doi: 10.2967/jnumed.123.265647.
    >> Share

    April 2023
  12. GRAEF J, Bluemel S, Brenner W, Amthauer H, et al
    [(177)Lu]Lu-PSMA Therapy as an Individual Treatment Approach for Patients with High-Grade Glioma: Dosimetry Results and Critical Statement.
    J Nucl Med. 2023 Apr 28:jnumed.122.264850. doi: 10.2967/jnumed.122.264850.
    >> Share

  13. SMITH NJ, Deaton TK, Territo W, Graner B, et al
    Hybrid (18)F-Fluoroethyltyrosine PET and MRI with Perfusion to Distinguish Disease Progression from Treatment-Related Change in Malignant Brain Tumors: The Quest to Beat the Toughest Cases.
    J Nucl Med. 2023 Apr 28:jnumed.122.265149. doi: 10.2967/jnumed.122.265149.
    >> Share

  14. GALLDIKS N, Lohmann P, Fink GR, Langen KJ, et al
    Amino Acid PET in Neurooncology.
    J Nucl Med. 2023 Apr 13:264859. doi: 10.2967/jnumed.122.264859.
    >> Share

    December 2022
  15. NABAVIZADEH A, Bagley SJ, Doot RK, Ware JB, et al
    Distinguishing Progression from Pseudoprogression in Glioblastoma Using (18)F-Fluciclovine PET.
    J Nucl Med. 2022 Dec 22:jnumed.122.264812. doi: 10.2967/jnumed.122.264812.
    >> Share

  16. BAILEY DL, Willowson KP, Harris M, Biggin C, et al
    (64)Cu Treatment Planning and (67)Cu Therapy with Radiolabelled SARTATE ([(64)Cu/(67)Cu]MeCOSAR-Octreotate) in Subjects with Unresectable Multifocal Meningioma - Initial Results for Human Imaging, Safety, Biodistribution and Radiation Dosimetry.
    J Nucl Med. 2022 Dec 2:jnumed.122.264586. doi: 10.2967/jnumed.122.264586.
    >> Share

  17. SCHLURMANN T, Waschulzik B, Combs S, Gempt J, et al
    Diagnostic utility of amino acid PET in the differential diagnosis of recurrent brain metastases and treatment-related changes: a meta-analysis.
    J Nucl Med. 2022 Dec 2:jnumed.122.264803. doi: 10.2967/jnumed.122.264803.
    >> Share

    November 2022
  18. KREBS S, Schwartz J, Grommes C, Young RJ, et al
    Detecting CXCR4 expression in meningioma on (68)Ga-Pentixafor PET.
    J Nucl Med. 2022 Nov 10. pii: jnumed.122.265127. doi: 10.2967/jnumed.122.265127.
    >> Share

    August 2022
  19. SHIN J, Parker MFL, Zhu I, Alanizi A, et al
    Antigen-dependent inducible T cell reporter system for PET imaging of breast cancer and glioblastoma.
    J Nucl Med. 2022 Aug 18. pii: jnumed.122.264284. doi: 10.2967/jnumed.122.264284.
    >> Share

    April 2022
  20. ROSEN J, Ceccon G, Bauer EK, Werner JM, et al
    Cost-effectiveness of (18)F-FET PET for early treatment response assessment in glioma patients following adjuvant temozolomide chemotherapy.
    J Nucl Med. 2022 Apr 14. pii: jnumed.122.263790. doi: 10.2967/jnumed.122.263790.
    >> Share

    March 2022
  21. ZARAGORI T, Verger A
    Reply to Letter to the Editor: "(18)F-FDOPA PET for the Noninvasive Prediction of Glioma Molecular Parameters: A Radiomics Study".
    J Nucl Med. 2022 Mar 17. pii: jnumed.122.264035. doi: 10.2967/jnumed.122.264035.
    >> Share

    February 2022
  22. FORAY C, Barca C, Winkeler A, Wagner S, et al
    Interrogating glioma-associated microglia/macrophage dynamics under CSF-1R therapy with multi-tracer in vivo PET/MR imaging.
    J Nucl Med. 2022 Feb 3. pii: jnumed.121.263318. doi: 10.2967/jnumed.121.263318.
    >> Share

    January 2022
  23. LANGEN KJ, Mottaghy FM
    Letter to the Editor: "(18)F-FDOPA PET for the Noninvasive Prediction of Glioma Molecular Parameters: A Radiomics Study" [J Nucl Med 2022; 63:147-157].
    J Nucl Med. 2022 Jan 27. pii: jnumed.122.263837. doi: 10.2967/jnumed.122.263837.
    >> Share

    November 2021
  24. NIMMAGADDA S
    Imaging PD-L1 expression in melanoma brain metastases.
    J Nucl Med. 2021 Nov 5. pii: jnumed.121.263209. doi: 10.2967/jnumed.121.263209.
    >> Share

    September 2021
  25. NIENHUIS PH, Antunes IF, Glaudemans AWJM, Jalving M, et al
    (18)F-BMS986192 PET imaging of PD-L1 in metastatic melanoma patients with brain metastases treated with immune checkpoint inhibitors. A pilot study.
    J Nucl Med. 2021 Sep 9. pii: jnumed.121.262368. doi: 10.2967/jnumed.121.262368.
    >> Share

    August 2021
  26. BAG AK, Wing MN, Sabin ND, Hwang SN, et al
    [(11)C]-Methionine PET for Identification of Pediatric High-Grade Glioma Recurrence.
    J Nucl Med. 2021 Aug 26. pii: jnumed.120.261891. doi: 10.2967/jnumed.120.261891.
    >> Share

  27. PARIHAR AS, Schmidt LR, Dehdashti F, Wahl RL, et al
    Detection of additional primary neoplasms on (18)F-Fluciclovine PET/CT in patients with primary prostate cancer.
    J Nucl Med. 2021 Aug 19. pii: jnumed.121.262647. doi: 10.2967/jnumed.121.262647.
    >> Share

  28. BRENDLE C, Maier C, Bender B, Schittenhelm J, et al
    Impact of (18)F-FET PET/MR on clinical management of brain tumor patients.
    J Nucl Med. 2021 Aug 5. pii: jnumed.121.262051. doi: 10.2967/jnumed.121.262051.
    >> Share

    July 2021
  29. VONKEN EPA, Bruijnen RCG, Snijders TJ, Seute T, et al
    Intra-arterial administration boosts (177)Lu-HA-DOTATATE accumulation in salvage meningioma patients.
    J Nucl Med. 2021 Jul 22. pii: jnumed.121.262491. doi: 10.2967/jnumed.121.262491.
    >> Share

  30. BASHARI WA, Senanayake R, MacFarlane J, Gillett D, et al
    Using Molecular Imaging to Enhance Decision Making in the Management of Pituitary Adenomas.
    J Nucl Med. 2021;62.
    >> Share

    May 2021
  31. ZARAGORI T, Oster J, Roch V, Hossu G, et al
    (18)F-FDOPA PET for the non-invasive prediction of glioma molecular parameters: a radiomics study.
    J Nucl Med. 2021 May 20. pii: jnumed.120.261545. doi: 10.2967/jnumed.120.261545.
    >> Share

  32. COLLET S, Guillamo JS, Berro DH, Chakhoyan A, et al
    Simultaneous mapping of vasculature, hypoxia and proliferation using DSC-MRI, (18)F-FMISO PET, and (18)F-FLT PET in relation to contrast enhancement in newly diagnosed glioblastoma.
    J Nucl Med. 2021 May 20. pii: jnumed.120.249524. doi: 10.2967/jnumed.120.249524.
    >> Share

    January 2021
  33. JIMENEZ-FRANCO LD, Glatting G, Prasad V, Weber WA, et al
    Effect of Tumor Perfusion and Receptor Density on Tumor Control Probability in (177)Lu-DOTATATE Therapy: An In Silico Analysis for Standard and Optimized Treatment.
    J Nucl Med. 2021;62:92-98.
    >> Share

    November 2020
  34. CECCON G, Lohmann P, Werner JM, Tscherpel C, et al
    Early treatment response assessment using (18)F-FET PET compared to contrast-enhanced MRI in glioma patients following adjuvant temozolomide chemotherapy.
    J Nucl Med. 2020 Nov 6. pii: jnumed.120.254243. doi: 10.2967/jnumed.120.254243.
    >> Share

    May 2020
  35. KRAMER K, Donzelli M, Nwora E, Pandit-Taskar N, et al
    Assessing Cerebrospinal Fluid Flow Dynamics in Pediatric Patients with Central Nervous System Tumors Treated with Intraventricular Radioimmunotherapy.
    J Nucl Med. 2020;61:662-664.
    >> Share

    April 2020
  36. HERHAUS P, Lipkova J, Lammer F, Yakushev I, et al
    CXCR4-targeted positron emission tomography imaging of central nervous system B-cell lymphoma.
    J Nucl Med. 2020 Apr 24. pii: jnumed.120.241703. doi: 10.2967/jnumed.120.241703.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016